Reistone Biopharma

company

About

Reistone Biopharma is a clinical stage biopharmaceutical company.

  • 101 - 250

Details

Last Funding Type
Series A
Last Funding Money Raised
$100M
Industries
Biotechnology,Pharmaceutical
Founded date
Jan 1, 2018
Number Of Employee
101 - 250
Operating Status
Active

Reistone Biopharma is a clinical stage biopharmaceutical company. It is focused on rapidly developing innovative medicines through global
collaborations within Research and Development

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$100M
Reistone Biopharma has raised a total of $100M in funding over 2 rounds. Their latest funding was raised on May 9, 2022 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 9, 2022 Series A $100M 3 Capital Healthcare Fund Detail

Investors

Number of Lead Investors
Number of Investors
1
3
Reistone Biopharma is funded by 3 investors. Capital Healthcare Fund and shodu healthcare fund are the most recent investors.
Investor Name Lead Investor Funding Round
Capital Healthcare Fund Yes Series A
shodu healthcare fund Series A
Shanghai Zhangjiang Haocheng Venture Capital Series A